BACKGROUND: Vasopressors administered IV late during resuscitation efforts fail to improve survival. Intraosseous (IO) access can provide a route for earlier administration. We hypothesized that IO epinephrine after 1 minute of cardiopulmonary resuscitation (CPR) (an "optimal" IO scenario) after 10 minutes of untreated ventricular fibrillation (VF) cardiac arrest would improve outcome in comparison with either IV epinephrine after 8 minutes of CPR (a "realistic" IV scenario) or placebo controls with no epinephrine. METHODS: Thirty swine were randomized to IO epinephrine, IV epinephrine, or placebo. Important outcomes included return of spontaneous circulation (ROSC), 24-hour survival, and 24-hour survival with good neurological outcome (cerebral performance category 1). RESULTS: ROSC after 10 minutes of untreated VF was uncommon without administration of epinephrine (1 of 10), whereas ROSC was nearly universal with IO epinephrine or delayed IV epinephrine (10 of 10 and 9 of 10, respectively; P = 0.001 for either versus placebo). Twenty-four hour survival was substantially more likely after IO epinephrine than after delayed IV epinephrine (10 of 10 vs. 4 of 10, P = 0.001). None of the placebo group survived at 24 hours. Survival with good neurological outcome was more likely after IO epinephrine than after placebo (6 of 10 vs. 0 of 10, P = 0.011), and only 3 of 10 survived with good neurological outcome in the delayed IV epinephrine group (not significant versus either IO or placebo). CONCLUSION: In this swine model of prolonged VF cardiac arrest, epinephrine administration during CPR improved outcomes. In addition, early IO epinephrine improved outcomes in comparison with delayed IV epinephrine.
BACKGROUND: Vasopressors administered IV late during resuscitation efforts fail to improve survival. Intraosseous (IO) access can provide a route for earlier administration. We hypothesized that IO epinephrine after 1 minute of cardiopulmonary resuscitation (CPR) (an "optimal" IO scenario) after 10 minutes of untreated ventricular fibrillation (VF) cardiac arrest would improve outcome in comparison with either IV epinephrine after 8 minutes of CPR (a "realistic" IV scenario) or placebo controls with no epinephrine. METHODS: Thirty swine were randomized to IO epinephrine, IV epinephrine, or placebo. Important outcomes included return of spontaneous circulation (ROSC), 24-hour survival, and 24-hour survival with good neurological outcome (cerebral performance category 1). RESULTS: ROSC after 10 minutes of untreated VF was uncommon without administration of epinephrine (1 of 10), whereas ROSC was nearly universal with IO epinephrine or delayed IV epinephrine (10 of 10 and 9 of 10, respectively; P = 0.001 for either versus placebo). Twenty-four hour survival was substantially more likely after IO epinephrine than after delayed IV epinephrine (10 of 10 vs. 4 of 10, P = 0.001). None of the placebo group survived at 24 hours. Survival with good neurological outcome was more likely after IO epinephrine than after placebo (6 of 10 vs. 0 of 10, P = 0.011), and only 3 of 10 survived with good neurological outcome in the delayed IV epinephrine group (not significant versus either IO or placebo). CONCLUSION: In this swine model of prolonged VF cardiac arrest, epinephrine administration during CPR improved outcomes. In addition, early IO epinephrine improved outcomes in comparison with delayed IV epinephrine.
Authors: Robert M Sutton; Dana Niles; Benjamin French; Matthew R Maltese; Jessica Leffelman; Joar Eilevstjønn; Heather Wolfe; Akira Nishisaki; Peter A Meaney; Robert A Berg; Vinay M Nadkarni Journal: Resuscitation Date: 2013-08-29 Impact factor: 5.262
Authors: Robert M Sutton; Benjamin French; Dana E Niles; Aaron Donoghue; Alexis A Topjian; Akira Nishisaki; Jessica Leffelman; Heather Wolfe; Robert A Berg; Vinay M Nadkarni; Peter A Meaney Journal: Resuscitation Date: 2014-05-16 Impact factor: 5.262
Authors: Heather Wolfe; Carleen Zebuhr; Alexis A Topjian; Akira Nishisaki; Dana E Niles; Peter A Meaney; Lori Boyle; Rita T Giordano; Daniela Davis; Margaret Priestley; Michael Apkon; Robert A Berg; Vinay M Nadkarni; Robert M Sutton Journal: Crit Care Med Date: 2014-07 Impact factor: 7.598
Authors: Mohamud R Daya; Brian G Leroux; Paul Dorian; Thomas D Rea; Craig D Newgard; Laurie J Morrison; Joshua R Lupton; James J Menegazzi; Joseph P Ornato; George Sopko; Jim Christenson; Ahamed Idris; Purav Mody; Gary M Vilke; Caroline Herdeman; David Barbic; Peter J Kudenchuk Journal: Circulation Date: 2020-01-16 Impact factor: 29.690
Authors: Don Johnson; Jose Garcia-Blanco; James Burgert; Lawrence Fulton; Patrick Kadilak; Katherine Perry; Jeffrey Burke Journal: Ann Med Surg (Lond) Date: 2015-08-22
Authors: Gavin D Perkins; Claire Kenna; Chen Ji; Charles D Deakin; Jerry P Nolan; Tom Quinn; Charlotte Scomparin; Rachael Fothergill; Imogen Gunson; Helen Pocock; Nigel Rees; Lyndsey O'Shea; Judith Finn; Simon Gates; Ranjit Lall Journal: Intensive Care Med Date: 2020-01-07 Impact factor: 17.440
Authors: Michael James Neill; James M Burgert; Dawn Blouin; Benjamin Tigges; Kari Rodden; Rachel Roberts; Phillip Anderson; Travis Hallquist; John Navarro; Joseph O'Sullivan; Don Johnson Journal: Trauma Surg Acute Care Open Date: 2020-02-18